Diamantopoulos P., Koumbi D., Kotsianidis I., Pappa V., Symeonidis A., Galanopoulos A., Zikos P., Papadaki H.A., Panayiotidis P., Dimou M., Hatzimichael E., Vassilopoulos G., Delimpasis S., Mparmparousi D., Papageorgiou S., Variami E., Kyrtsonis M.-C., Megalakaki A., Kotsopoulou M., Repousis P., Adamopoulos I., Kontopidou F., Christoulas D., Kourakli A., Tsokanas D., Konstantinos Papoutselis M., Kyriakakis G., Viniou N.-A., the Hellenic MDS study group (2019)
In patients with myelodysplastic syndrome (MDS), the prognostic significance of chromosome 17 abnormalities has not yet been fully elucidated, except for isochromosome 17q that has been characterized as an intermediate ...